ICL Group Ltd acquired Lavie Bio's activity and Evogene's AI platform, benefiting from market trends like tariffs and onshoring.
3 reports, 2 independent
Updated Aug 24
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ICL Group Ltd acquired Lavie Bio's activity and Evogene's AI platform, benefiting from market trends like tariffs and onshoring.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Icl Group Ltd
Global manufacturer of mineral based products
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyEvogene Declares The Sale Of Lavie Bio’s Activity To ICL Completed ICL Group Ltd (NYSE:ICL) is among the 13 Best Magnesium Stocks to Invest in Now. Evogene Ltd. announced the successful sale of its a
- PR NewswireEvogene Reports Second Quarter 2025 Financial Results Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie B
- Unknown outlet